JeanPaul MD - Inventiva Head Pharmacovigilance
| IVEVF Stock | USD 3.64 0.00 0.00% |
Insider
JeanPaul MD is Head Pharmacovigilance of Inventiva SA
| Phone | 33 3 80 44 75 00 |
| Web | https://www.inventivapharma.com |
Inventiva Management Efficiency
The company has return on total asset (ROA) of (0.3438) % which means that it has lost $0.3438 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7073) %, meaning that it generated substantial loss on money invested by shareholders. Inventiva's management efficiency ratios could be used to measure how well Inventiva manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Manuel Fernandez | Jacobs Solutions | 58 | |
| Ramesh Nuggihalli | CECO Environmental Corp | N/A | |
| Priya Abani | Jacobs Solutions | 45 | |
| Linda Levinson | Jacobs Solutions | 77 | |
| Todd Gleason | CECO Environmental Corp | 53 | |
| Jarrod Langhans | Celsius Holdings | 43 | |
| KwonPing Ho | Diageo PLC ADR | 67 | |
| Jonathan Doros | Jacobs Solutions | N/A | |
| Vincent Brooks | Jacobs Solutions | 62 | |
| Georgette Kiser | Jacobs Solutions | 53 | |
| Halima Aden | Vita Coco | N/A | |
| Paul Gohr | CECO Environmental Corp | 42 | |
| Ira Liran | Vita Coco | 45 | |
| Jon McKillop | Celsius Holdings | N/A | |
| Rowena Ricalde | Vita Coco | 43 | |
| Marietta Hannigan | Jacobs Solutions | N/A | |
| Jane Prior | Vita Coco | 45 | |
| Cristina Diezhandino | Diageo PLC ADR | 57 | |
| Ralph Eberhart | Jacobs Solutions | 74 | |
| William Allen | Jacobs Solutions | 60 | |
| Jonathan Burth | Vita Coco | 42 | |
Management Performance
| Return On Equity | -0.71 | |||
| Return On Asset | -0.34 |
Inventiva SA Leadership Team
Elected by the shareholders, the Inventiva's board of directors comprises two types of representatives: Inventiva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inventiva. The board's role is to monitor Inventiva's management team and ensure that shareholders' interests are well served. Inventiva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inventiva's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jean Volatier, Chief Officer | ||
| Eric LLM, G Counsel | ||
| Frederic Cren, CEO, Co-Founder | ||
| JeanPaul MD, Head Pharmacovigilance | ||
| Michael Cooreman, Chief Officer | ||
| Pierre Broqua, Co-Founder, Chief Scientific Officer | ||
| Irena Konstantinova, Head of Fibrosis Research | ||
| Nathalie Harroy, Head of Human Resources |
Inventiva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Inventiva a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (6.37) % | |||
| Current Valuation | 108.8 M | |||
| Shares Outstanding | 42.13 M | |||
| Shares Owned By Insiders | 25.11 % | |||
| Shares Owned By Institutions | 46.96 % | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 21.40 X | |||
| Revenue | 4.19 M |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inventiva Pink Sheet
When determining whether Inventiva SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inventiva SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Stocks Directory module to find actively traded stocks across global markets.